Core Points - The announcement confirms the authenticity and completeness of the financial report for the first quarter of 2025, which was approved by the board of directors [2][12][14] - The financial statements are prepared in accordance with Chinese accounting standards and have not been audited [3][4] - The report includes a retrospective adjustment of accounting data due to a change in accounting policy as per the Ministry of Finance's announcement [5] Financial Data - The report indicates that the company has made adjustments to its operating costs and sales expenses for the first quarter of 2024 due to the new accounting interpretation [5] - Non-recurring gains and losses are defined according to the relevant regulations, but specific amounts are not detailed in the provided text [6] - The company has not reported any changes in accounting estimates or corrections of accounting errors [6] Shareholder Information - As of March 31, 2025, all top ten shareholders hold unrestricted shares, and their holdings are consistent across different categories [7][8] - The report notes that there are no preferred shares issued by the company [9] Board and Supervisory Meetings - The board meeting held on April 22, 2025, was conducted via video conference, with a majority of directors present [10][11] - The supervisory board also held a meeting on the same day, confirming the legality and validity of the procedures followed in preparing the financial report [13][14]

截至2024年12月31日，本公司募集资金在银行一般户的存储情况如下： 单位：元 ■ 注1： 截至2024年12月31日，部分公司募集资金已依据既定用途使用完毕并完成销户。 三、本年度募集资金的实际使用情况 （一）募集资金投资项目（以下简称"募投项目"）的资金使用情况 公司2024年度募集资金实际使用情况详见附表1《募集资金使用情况对照表》。 （二）募投项目先期投入及置换情况 截至2021年10月15日（募集资金实际到账日），公司已通过自筹资金进行募集资金投资项目的投资金额 合计为人民币15,911.57万元，具体情况如下： ■ 立信会计师事务所（特殊普通合伙）已对上述自筹资金预先投入募投项目的情况进行了专项审核，并出 具了信会师报字[2021]第ZA15835号《关于宁波德昌电机股份有限公司以自筹资金预先投入募投项目的 鉴证报告》。 公司于2021年12月10日召开第一届董事会第十三次会议、第一届监事会第九次会议，审议通过《关于公 司以募集资金置换预先投入募投项目自筹资金的议案》，同意使用募集资金人民币15,911.57万元置换预 先已投入募投项目的自筹资金。中信证券股份有限公司（以下简称"中信证券"）发表 ...

Group 1 - The core point of the announcement is the change in accounting policies by Guangdong Changqing (Group) Co., Ltd. based on revised accounting standards issued by the Ministry of Finance, which will not have a significant impact on the company's net profit, total assets, or net assets [2][14]. - The accounting policy change is due to the issuance of "Interpretation No. 17" and "Interpretation No. 18" by the Ministry of Finance, which will be implemented starting January 1, 2024 [2][3]. - The company will continue to follow the previous accounting standards and guidelines for all other aspects not affected by this change [5]. Group 2 - The specific changes include the classification of current and non-current liabilities, disclosure requirements for supplier financing arrangements, and accounting treatment for sale-and-leaseback transactions [6][12]. - The company will classify liabilities based on the substantive rights to defer settlement beyond one year from the balance sheet date, regardless of the company's intentions [7]. - The company is required to disclose information regarding supplier financing arrangements to help users assess the impact on liabilities and liquidity risks [10]. Group 3 - The company plans to increase its registered capital from RMB 741,955,382 to RMB 742,023,734 due to the conversion of convertible bonds, with a total of 68,352 shares converted during the specified period [32]. - The company will amend its articles of association accordingly and will follow the relevant legal procedures for registration changes [33].

Group 1 - The company has applied for a total credit limit of RMB 16 million from various banks to support the daily operational liquidity of its subsidiary, Nengrui Electric [1][2] - The credit limits include RMB 3 million from Industrial Bank, RMB 3 million from Ningbo Bank, RMB 4 million from Agricultural Bank, and RMB 6 million from China Construction Bank [1][2] - The company will provide joint liability guarantees for these credit applications, which are expected to positively impact the business development of Nengrui Electric [1][2] Group 2 - The company has reported a total of RMB 31,095.91 million in external guarantees, which accounts for 13.6% of its latest audited net assets [2] - There are no overdue guarantees or violations related to external guarantees reported by the company [2] Group 3 - The company has announced a provision for asset impairment totaling RMB 24,313.76 million, which includes RMB 17,401.69 million for asset impairment and RMB 6,912.08 million for credit impairment [4][5] - The impairment provisions are based on comprehensive testing of goodwill, long-term equity investments, inventory, and other receivables as of December 31, 2024 [4][5] Group 4 - The company has recognized a goodwill impairment of RMB 6,973.74 million related to the acquisition of Nengrui Co., which had a carrying amount exceeding its recoverable amount [6][7] - Long-term equity investment impairment provisions amount to RMB 5,556.08 million due to significant impairment indicators from associated companies [7] Group 5 - The company has also recorded inventory impairment losses of RMB 4,898.05 million, reflecting the lower net realizable value of its inventory [8] - The total impact of these impairment provisions has reduced the company's consolidated profit for the year 2024 by RMB 24,313.76 million before tax considerations [8][9] Group 6 - The company has announced a change in accounting policies effective January 1, 2024, in accordance with new regulations issued by the Ministry of Finance [30][31] - The changes are not expected to have a significant impact on the company's financial position or operating results [30][31]

登录新浪财经APP 搜索【信披】查看更多考评等级 按照公司《经理层成员任期制与契约化管理细则》规定，公司董事会在高级管理人员2024年度薪酬考核 方案中明确了2024年度风险保证金的提取比例及方式。具体为："公司高级管理人员2024年度风险保证 金按个人绩效年薪10%的标准提取。提取方式：从拟考核兑现的高级管理人员个人年度薪酬总额中扣 除"。据此，公司高级管理人员2024年度风险保证金提取情况如下： ■ 三、公司高级管理人员2025年度薪酬考核方案 为充分调动公司经营管理团队的积极性和创造性，根据《公司章程》《董事会薪酬与考核委员会工作规 则》《经理层成员任期制与契约化管理细则》等规定，结合公司年度经营目标及所处行业实际，特制定 2025年度公司高级管理人员薪酬考核方案。内容如下： （一）适用对象 公司总裁，副总裁级别高级管理人员。其中，副总裁级别高级管理人员指公司副总裁、财务总监、董事 会秘书、总工程师（以上人员均为专职）。 （二）年度薪酬 1.年度薪酬的构成 年度薪酬由基本年薪和绩效年薪两部分组成。其中： 2.年度薪酬基数的设定 ○年度考核得分为70分（不含）以下的，评价系数值设定为0.7。 依据公司高级 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 二、本次会计政策变更对公司的影响 本次会计政策变更是公司根据财政部修订的最新会计准则进行的相应变更，符合相关法律法规的规定和 公司实际情况，不会对公司财务状况、经营成果和现金流量产生重大影响，不存在损害公司及全体股东 利益的情形。 三、董事会对本次会计政策变更合理性的说明 经审核，董事会认为：本次会计政策变更是公司根据财政部发布的《企业会计准则解释第18号》（财会 〔2024〕24号）的要求进行的相应变更，符合相关法律法规的规定和公司实际情况，不存在损害公司和 全体股东利益的情形。因此，董事会同意本次会计政策的变更。 四、监事会关于会计政策变更的意见 经审核，监事会认为：本次会计政策变更是根据财政部相关文件要求进行的合理变更，符合《企业会计 准则》及相关规定，符合公司实际情况，能够客观、公允地反映公司的财务状况和经营成果，本次会计 政策变更的决策程序符合有关法律、法规和《公司章程》的规定，不存在损害公司和中小股东利益的情 形。 五、备查文件 1、公司第四届董事会第五次会议决议； 2、公司第四届监事会第五次会议决议。 特此公告。 上海优宁维生物科技股份有限公司董 ...

四、董事会审计委员会关于公司本次计提资产减值准备的审议情况及意见 公司于2025年4月10日召开了第六届董事会审计委员会2025年第二次会议，会议以3票同意、0票反对、0 票弃权通过了《关于2024年度计提资产减值准备的议案》。审计委员会认为，公司本次计提资产减值准 备遵照并符合《企业会计准则》和公司相关会计政策的规定，本次计提资产减值准备基于谨慎性原则， 依据充分，符合公司资产现状，有助于更加公允地反映截止2024年12月31日公司的财务状况、资产价值 及经营成果，使公司关于资产价值的会计信息更加真实可靠，更具合理性。 登录新浪财经APP 搜索【信披】查看更多考评等级 3、本公司于资产负债表日对除金融资产之外的非流动资产判断是否存在可能发生减值的迹象。对使用 寿命不确定的无形资产，除每年进行的减值测试外，当其存在减值迹象时，也进行减值测试。其他除金 融资产之外的非流动资产，当存在迹象表明其账面金额不可收回时，进行减值测试。本公司至少每年测 试商誉是否发生减值。 五、监事会意见 依据《企业会计准则》《深圳证券交易所上市公司自律监管指引第1号一一主板上市公司规范运作》 《深圳证券交易所股票上市规则》等相关法律、 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 公司于2025年4月19日召开第六届董事会第十六次会议，审议通过《关于续聘公司2025年审计机构的议 案》，全体董事以9票同意，0票反对，0票弃权的表决结果通过了此项议案。 （三）生效日期 本次续聘2025年审计机构事项尚需提交公司2024年度股东大会审议，并自公司股东大会审议通过之日起 生效。 三、备查文件 1. 经与会董事签字并加盖董事会印章的第六届董事会第十六次会议决议； 2. 经与会监事签字并加盖监事会印章的第六届监事会第十二次会议决议； 3. 第六届董事会审计委员会2025年第二次会议决议； 证券代码：002378 证券简称：章源钨业 编号：2025-022 崇义章源钨业股份有限公司 4. 拟聘任会计师事务所关于其基本情况的说明。 特此公告。 崇义章源钨业股份有限公司董事会 2025年4月22日 关于2025年向金融机构申请综合 授信额度、非金融机构申请融资额度 及提供抵押或质押担保的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 崇义章源钨业股份有限公司（以下简称"公司"）于2025年4月19 ...

Core Viewpoint - The company, 罗欣药业集团股份有限公司, has announced significant financial adjustments including asset impairment provisions and fair value changes, which collectively reduce the total profit for 2024 by 52,796.55 million RMB [18][23]. Group 1: Company Overview - 罗欣药业 was established on June 25, 2014, with a registered capital of 600 million RMB, located in Shanghai Free Trade Zone [2]. - The company operates in various sectors including medical research, technology services, and sales of medical devices and chemicals [2][6]. Group 2: Financial Data - The company reported a total impairment provision of 31,483.46 million RMB for 2024, which includes provisions for receivables, inventory, and other assets [23]. - The fair value change loss recognized was -21,313.09 million RMB, primarily due to the performance of its subsidiary, 上药罗欣, which fell short of its performance commitments [22][23]. Group 3: Guarantee Agreements - The company and its subsidiaries will enter into guarantee agreements with financial institutions to enhance financing efficiency and reduce costs, with a total guarantee amount of 273,800 million RMB, representing 198.08% of the latest audited net assets [12][10]. - The total balance of external guarantees after this agreement will be 81,273.62 million RMB, accounting for 58.80% of the latest audited net assets [12]. Group 4: Accounting Policy Changes - The company has changed its accounting policy in accordance with the Ministry of Finance's new regulations, which will not significantly impact its financial status or results [14][17]. - The new policy is aimed at better reflecting the company's financial condition and operational results [17].

Group 1 - The company emphasizes the importance of using simple, liquid, and low-risk foreign exchange derivatives for hedging against currency fluctuations [1][2] - The company has established management systems for futures and derivatives trading, detailing organizational structure, responsibilities, and risk management [1][3] - The company aims to mitigate adverse impacts from raw material price and exchange rate fluctuations through hedging operations in futures and derivatives markets [3][27] Group 2 - The company will hold its 2024 annual shareholders' meeting on May 20, 2025, with both on-site and online voting options available [5][6] - The meeting will take place at the company's administrative building in Guangzhou, and shareholders must register to attend [7][15] - The company has outlined the voting procedures for various types of shareholders, including those participating through margin trading and the Shanghai-Hong Kong Stock Connect [8][10] Group 3 - The company has announced a provision for asset impairment and recognition of fair value changes for non-current financial assets, totaling a reduction in profit of 614.25 million yuan for the year 2024 [19][27] - The impairment provisions include amounts for receivables, inventory, fixed assets, and goodwill, reflecting a cautious approach to financial reporting [19][21][26] - The company has confirmed fair value losses for non-current financial assets amounting to 38.12 million yuan, indicating a need for careful asset management [20][27] Group 4 - The company has implemented a change in accounting policy in accordance with the Ministry of Finance's new guidelines, which will not significantly impact its financial results [29][30] - The new accounting policy, effective from January 1, 2024, relates to the measurement of investment properties and quality assurance guarantees [31][32] Group 5 - The company has reported its fourth-quarter operational data for 2024, including production and sales figures for modified plastics, green petrochemicals, and new materials [34][38] - The sales volume for modified plastics reached 699,300 tons, while green petrochemical products and new materials also showed significant sales figures [34][39] - The company has noted no other significant operational impacts during the reporting period [38][39]